Literature DB >> 11597692

Importance of perspective in economic analyses of cancer screening decisions.

E C Mansley1, M T McKenna.   

Abstract

As the fifth, and final, report in this Lancet series on health economics, we discuss how economic analyses in public health, with cancer screening as the example, differ depending on the perspective taken. We identify nine different, but related, decision makers at various levels, from the individual patient to society as a whole, and discuss how their different viewpoints affect their ultimate decisions. Central to our discussion is the identification of seven distinct components of perspective, each potentially important in the screening decision. In many fields of healthcare, decisions about the use of resources, such as time, wealth, or energy, are made by weighing up the positive and negative consequences of the alternatives under consideration and are thus based on an economic analysis of the situation (although sometimes this process is subconscious). For simplicity, we restrict our report to the effect of perspective on cancer screening decisions and show how the costs (negative consequences) and benefits (positive consequences) vary depending on the decision maker.

Entities:  

Mesh:

Year:  2001        PMID: 11597692     DOI: 10.1016/S0140-6736(01)06258-4

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  2 in total

1.  Cost-effectiveness of new tests to diagnose and treat coronary heart disease.

Authors:  Leslee J Shaw; Allen J Taylor; Patrick G O'Malley
Journal:  Curr Treat Options Cardiovasc Med       Date:  2005-08

2.  Economic evaluation of three populational screening strategies for cervical cancer in the county of Valles Occidental: CRICERVA clinical trial.

Authors:  Amelia Acera; Ana Rodriguez; Marta Trapero-Bertran; Pilar Soteras; Norman Sanchez; Josep M Bonet; Josep M Manresa; Pablo Hidalgo; Pere Toran; Gemma Prieto
Journal:  BMC Health Serv Res       Date:  2011-10-19       Impact factor: 2.655

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.